Herpes zoster eye complications: Rates and trends

Barbara P. Yawn, Peter C. Wollan, Jennifer St. Sauver, Linda C. Butterfield

Research output: Contribution to journalArticle

70 Citations (Scopus)

Abstract

Purpose: To provide population-based data on the risk, types, and outcomes of eye involvement in herpes zoster (HZ). Methods: A cohort study based on review of the medical records of patients in whom HZ was diagnosed between January 1, 1980, and December 31, 2007, was performed. Herpes zoster was confirmed by the presence of the typical rash and symptoms or by laboratory testing, and eye involvement was confirmed by ophthalmologists' evaluation. Information was collected on all eye diagnoses and on HZ eye-related visits, treatments, procedures, and outcomes. Results: Of the 7370 individuals with HZ in any dermatome, 184 (2.5%) had eye involvement. The mean age of the 184 was 62.6 years, and 5 cases occurred in patients younger than 21. Overall, 6.5% (12) were immunosuppressed at the time of the eye complications. The rate of increase in HZ eye involvement was 23% by decade from 1980 to 2007. Common eye complications were keratitis (n=144, 76.2%), uveitis/ iritis (n=88, 46.6%), and conjunctivitis (n=67, 35.4%). Recurrent keratitis and recurrent iritis/uveitis occurred in 6.9% (13) and 7.4% (14), respectively. Outcomes included 6 patients (3.3%) with new vision decrements to 20/200 or worse. Two individuals had successful corneal transplants. Another 6 individuals (3.3%) had lid ptosis that affected vision, including 1 elderly woman with permanent unilateral tarsorrhaphy. Severe HZ eye pain was reported to be directly responsible for 1 unsuccessful suicide attempt. Acute retinal necrosis did not develop in any individual. A mean of 10.8 eye visits per patient with HZ and eye involvement was reported to continue for a mean of 308 days. Conclusion: Eye complications are common and result in considerable health care use and permanent vision decrement in about 6.6% (6) of individuals with HZ eye involvement. Most health care use and long-term adverse outcomes occurred in patients in whom prevention of HZ with the zoster vaccine would be possible.

Original languageEnglish (US)
Pages (from-to)562-570
Number of pages9
JournalMayo Clinic Proceedings
Volume88
Issue number6
DOIs
StatePublished - Jun 2013

Fingerprint

Herpes Zoster
Iritis
Keratitis
Uveitis
Herpes Zoster Vaccine
Acute Retinal Necrosis Syndrome
Eye Pain
Delivery of Health Care
Conjunctivitis
Exanthema
Suicide
Medical Records
Cohort Studies
Transplants

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Herpes zoster eye complications : Rates and trends. / Yawn, Barbara P.; Wollan, Peter C.; St. Sauver, Jennifer; Butterfield, Linda C.

In: Mayo Clinic Proceedings, Vol. 88, No. 6, 06.2013, p. 562-570.

Research output: Contribution to journalArticle

Yawn, Barbara P. ; Wollan, Peter C. ; St. Sauver, Jennifer ; Butterfield, Linda C. / Herpes zoster eye complications : Rates and trends. In: Mayo Clinic Proceedings. 2013 ; Vol. 88, No. 6. pp. 562-570.
@article{404a43cff1d94db2a345f75290e9b429,
title = "Herpes zoster eye complications: Rates and trends",
abstract = "Purpose: To provide population-based data on the risk, types, and outcomes of eye involvement in herpes zoster (HZ). Methods: A cohort study based on review of the medical records of patients in whom HZ was diagnosed between January 1, 1980, and December 31, 2007, was performed. Herpes zoster was confirmed by the presence of the typical rash and symptoms or by laboratory testing, and eye involvement was confirmed by ophthalmologists' evaluation. Information was collected on all eye diagnoses and on HZ eye-related visits, treatments, procedures, and outcomes. Results: Of the 7370 individuals with HZ in any dermatome, 184 (2.5{\%}) had eye involvement. The mean age of the 184 was 62.6 years, and 5 cases occurred in patients younger than 21. Overall, 6.5{\%} (12) were immunosuppressed at the time of the eye complications. The rate of increase in HZ eye involvement was 23{\%} by decade from 1980 to 2007. Common eye complications were keratitis (n=144, 76.2{\%}), uveitis/ iritis (n=88, 46.6{\%}), and conjunctivitis (n=67, 35.4{\%}). Recurrent keratitis and recurrent iritis/uveitis occurred in 6.9{\%} (13) and 7.4{\%} (14), respectively. Outcomes included 6 patients (3.3{\%}) with new vision decrements to 20/200 or worse. Two individuals had successful corneal transplants. Another 6 individuals (3.3{\%}) had lid ptosis that affected vision, including 1 elderly woman with permanent unilateral tarsorrhaphy. Severe HZ eye pain was reported to be directly responsible for 1 unsuccessful suicide attempt. Acute retinal necrosis did not develop in any individual. A mean of 10.8 eye visits per patient with HZ and eye involvement was reported to continue for a mean of 308 days. Conclusion: Eye complications are common and result in considerable health care use and permanent vision decrement in about 6.6{\%} (6) of individuals with HZ eye involvement. Most health care use and long-term adverse outcomes occurred in patients in whom prevention of HZ with the zoster vaccine would be possible.",
author = "Yawn, {Barbara P.} and Wollan, {Peter C.} and {St. Sauver}, Jennifer and Butterfield, {Linda C.}",
year = "2013",
month = "6",
doi = "10.1016/j.mayocp.2013.03.014",
language = "English (US)",
volume = "88",
pages = "562--570",
journal = "Mayo Clinic Proceedings",
issn = "0025-6196",
publisher = "Elsevier Science",
number = "6",

}

TY - JOUR

T1 - Herpes zoster eye complications

T2 - Rates and trends

AU - Yawn, Barbara P.

AU - Wollan, Peter C.

AU - St. Sauver, Jennifer

AU - Butterfield, Linda C.

PY - 2013/6

Y1 - 2013/6

N2 - Purpose: To provide population-based data on the risk, types, and outcomes of eye involvement in herpes zoster (HZ). Methods: A cohort study based on review of the medical records of patients in whom HZ was diagnosed between January 1, 1980, and December 31, 2007, was performed. Herpes zoster was confirmed by the presence of the typical rash and symptoms or by laboratory testing, and eye involvement was confirmed by ophthalmologists' evaluation. Information was collected on all eye diagnoses and on HZ eye-related visits, treatments, procedures, and outcomes. Results: Of the 7370 individuals with HZ in any dermatome, 184 (2.5%) had eye involvement. The mean age of the 184 was 62.6 years, and 5 cases occurred in patients younger than 21. Overall, 6.5% (12) were immunosuppressed at the time of the eye complications. The rate of increase in HZ eye involvement was 23% by decade from 1980 to 2007. Common eye complications were keratitis (n=144, 76.2%), uveitis/ iritis (n=88, 46.6%), and conjunctivitis (n=67, 35.4%). Recurrent keratitis and recurrent iritis/uveitis occurred in 6.9% (13) and 7.4% (14), respectively. Outcomes included 6 patients (3.3%) with new vision decrements to 20/200 or worse. Two individuals had successful corneal transplants. Another 6 individuals (3.3%) had lid ptosis that affected vision, including 1 elderly woman with permanent unilateral tarsorrhaphy. Severe HZ eye pain was reported to be directly responsible for 1 unsuccessful suicide attempt. Acute retinal necrosis did not develop in any individual. A mean of 10.8 eye visits per patient with HZ and eye involvement was reported to continue for a mean of 308 days. Conclusion: Eye complications are common and result in considerable health care use and permanent vision decrement in about 6.6% (6) of individuals with HZ eye involvement. Most health care use and long-term adverse outcomes occurred in patients in whom prevention of HZ with the zoster vaccine would be possible.

AB - Purpose: To provide population-based data on the risk, types, and outcomes of eye involvement in herpes zoster (HZ). Methods: A cohort study based on review of the medical records of patients in whom HZ was diagnosed between January 1, 1980, and December 31, 2007, was performed. Herpes zoster was confirmed by the presence of the typical rash and symptoms or by laboratory testing, and eye involvement was confirmed by ophthalmologists' evaluation. Information was collected on all eye diagnoses and on HZ eye-related visits, treatments, procedures, and outcomes. Results: Of the 7370 individuals with HZ in any dermatome, 184 (2.5%) had eye involvement. The mean age of the 184 was 62.6 years, and 5 cases occurred in patients younger than 21. Overall, 6.5% (12) were immunosuppressed at the time of the eye complications. The rate of increase in HZ eye involvement was 23% by decade from 1980 to 2007. Common eye complications were keratitis (n=144, 76.2%), uveitis/ iritis (n=88, 46.6%), and conjunctivitis (n=67, 35.4%). Recurrent keratitis and recurrent iritis/uveitis occurred in 6.9% (13) and 7.4% (14), respectively. Outcomes included 6 patients (3.3%) with new vision decrements to 20/200 or worse. Two individuals had successful corneal transplants. Another 6 individuals (3.3%) had lid ptosis that affected vision, including 1 elderly woman with permanent unilateral tarsorrhaphy. Severe HZ eye pain was reported to be directly responsible for 1 unsuccessful suicide attempt. Acute retinal necrosis did not develop in any individual. A mean of 10.8 eye visits per patient with HZ and eye involvement was reported to continue for a mean of 308 days. Conclusion: Eye complications are common and result in considerable health care use and permanent vision decrement in about 6.6% (6) of individuals with HZ eye involvement. Most health care use and long-term adverse outcomes occurred in patients in whom prevention of HZ with the zoster vaccine would be possible.

UR - http://www.scopus.com/inward/record.url?scp=84880230210&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84880230210&partnerID=8YFLogxK

U2 - 10.1016/j.mayocp.2013.03.014

DO - 10.1016/j.mayocp.2013.03.014

M3 - Article

C2 - 23664666

AN - SCOPUS:84880230210

VL - 88

SP - 562

EP - 570

JO - Mayo Clinic Proceedings

JF - Mayo Clinic Proceedings

SN - 0025-6196

IS - 6

ER -